Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

PFIZER LTD. - 500680 - Board Meeting Intimation for Board Meeting For The Unaudited Financial Results For The Quarter Ended June 30, 2020.

 PFIZER LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2020 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, July 27, 2020, inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter ended June 30, 2020. Pursuant to the 'Pfizer Limited - Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders', the Trading Window of the Company was closed from Wednesday, July 1, 2020 till 48 hours after the results are made public on July 27, 2020. We request you to kindly take the same on record.
17-07-2020
Bigul

PFIZER LTD. - 500680 - Disclosure Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')

 Pursuant to Regulation 23(9) of the Listing Regulations, please find enclosed, disclosure of related party transactions on a consolidated basis, in the format specified in the accounting standards for the year ended March 31, 2020. The said disclosure is also available on the website of the Company i.e., www.pfizerindia.com. Please take the above on record.
14-07-2020
Bigul

PFIZER LTD. - 500680 - Shareholding for the Period Ended June 30, 2020

 Pfizer Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here
14-07-2020
Bigul

Pfizer, BioNTech's Covid-19 vaccines get US FDA's 'fast track' status

 If the ongoing studies are successful, and the vaccine candidate receives regulatory approval, the companies said they expect to make up to 100 million doses by the end of this year
13-07-2020
Bigul

Broker's call: Pfizer (Buy)

 ICICI Direct Pfizer (Buy)Target: 4,740CMP: 4,090.15Pfizer's Q4-FY20 revenues declined 6.3 per cent YoY to 502 crore due to divestiture of certain b
10-07-2020
Bigul

PFIZER LTD. - 500680 - Statement Of Investor Complaints For The Quarter Ended June 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 030300 Name of the Signatory :- PRAJEET NAIRDesignation :- Company Secretary and Compliance Officer
10-07-2020
Bigul

PFIZER LTD. - 500680 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Certificate under Regulation 74(5) of SEBI (Depositories and Participants)Regulations, 2018 for the quarter ended June 30, 2020.
09-07-2020
Bigul

PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation regarding loss of share certificates and issue of duplicate share certificates
09-07-2020
Bigul

Coronavirus vaccine update: Early trials by Pfizer, BioNTech show encouraging results

 Coronavirus vaccine update: A coronavirus vaccine candidate tested by American firm Pfizer and German biotech major BioNTech SE has been found to generate antibodies in people, a study showed
03-07-2020
Bigul

PFIZER LTD. - 500680 - Pfizer Limited - Important Communication For Shareholders

 Enclosed herewith please find an important communication dated June 30, 2020, by Pfizer Limited to its Shareholders with respect to claiming the unclaimed dividend, updation of e-mail ID, Bank Mandate & KYC details and transfer of shares of the shareholders who have not claimed the dividend for previous seven consecutive years (i.e., From March 31, 2013) to Ministry of Corporate Affairs IEPF Account. Please take the above on record.
30-06-2020
Next Page
Close

Let's Open Free Demat Account